| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.09 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |